MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 BARD® NASOGASTRIC SUMP TUBE WITH PREVENT® ANTI-REFLUX FILTER; NASOGASTRIC TUBE

Catalog Number	0046160
Medical Device Problem Code	Unclear Information (4052)
Health Effect - Clinical Code	No Clinical Signs, Symptoms or Conditions (4582)
Date of Event	11/26/2024
Type of Reportable Event	Malfunction
Event or Problem Description
It was reported that the newer models of nasal gastric tubes did not have marking numbers indicating how far the tube had been inserted.There were just black marks thus leading to confusion if the tube was still placed in the correct spot.They were unable to find another ng tube on the website product list with number markings.Per follow up via email on 26nov2024, it was reported that the issue that they were facing was that bards tubes did not have clear markings.There were some small black markings, but they were too far spaced out to be safely used and there was not a number marking with the black lines.The caregivers swap out every 12 hours and to tell the next caregiver that the ng tube was 3 cm from the 3rd black line did not work because there was nowhere to chart something like that with their current emr.Their charting had them put how far the line was inserted.To figure that out, they would need to know how long the total line was, measure how much of the line was out of the patient and then subtract that from the total line amount.They had tried using tape or a marker to mark the insertion point but the tape moved with time and the marking from a marker or too easily erased.As a safety issue, the nurses were requesting that bard consider adding clear markings to the ng tubes.They had 3 that they order, 0046140, 0046160, 0046180.
Additional Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Additional Manufacturer Narrative
The reported event was inconclusive because this investigation did not result in any additional findings and no sample was available for evaluation.No additional actions can be taken at this time since root cause was not identified.The dhr review could not be performed without a lot number.A labeling review was not required because labeling could not have prevented the reported issue.Udi format updated with available product information per gudid.H11: section a through f - the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
Event or Problem Description
It was reported that the newer models of nasal gastric tubes did not have marking numbers indicating how far the tube had been inserted.There were just black marks thus leading to confusion if the tube was still placed in the correct spot.They were unable to find another ng tube on the website product list with number markings.Per follow up via email on 26nov2024, it was reported that the issue that they were facing was that bards tubes did not have clear markings.There were some small black markings, but they were too far spaced out to be safely used and there was not a number marking with the black lines.The caregivers swap out every 12 hours and to tell the next caregiver that the ng tube was 3 cm from the 3rd black line did not work because there was nowhere to chart something like that with their current emr.Their charting had them put how far the line was inserted.To figure that out, they would need to know how long the total line was, measure how much of the line was out of the patient and then subtract that from the total line amount.They had tried using tape or a marker to mark the insertion point but the tape moved with time and the marking from a marker or too easily erased.As a safety issue, the nurses were requesting that bard consider adding clear markings to the ng tubes.They had 3 that they order, 0046140, 0046160, 0046180.

• Brand Name: BARD® NASOGASTRIC SUMP TUBE WITH PREVENT® ANTI-REFLUX FILTER
• Common Device Name: NASOGASTRIC TUBE
• Manufacturer (Section D): C.R. BARD, INC. (COVINGTON) -1018233; 8195 industrial blvd; covington 30014
• Manufacturer (Section G): C.R. BARD INC. (COVINGTON) -1018233; 8195 industrial blvd; covington GA 30014
• Manufacturer Contact: xeeroy rada ; 8195 industrial blvd; covington 30014 ; 7707846100
• MDR Report Key: 20926193
• Report Number: 1018233-2024-08005
• Device Sequence Number: 5105757
• Product Code: FEG
• UDI-Device Identifier: 00801741052323
• UDI-Public: (01)00801741052323
• Combination Product (Y/N): N
• Initial Reporter State: UT
• Initial Reporter Country: US
• PMA/510(K) Number: K960176
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Reporter Type: Manufacturer
• Report Source: Other,Company Representative
• Initial Reporter Occupation: Physician
• Type of Report: Initial,Followup
• Report Date (Section B): 01/23/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: No
• Is this a Product Problem Report?: Yes
• Operator of Device: Health Professional
• Device Catalogue Number: 0046160
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 11/26/2024
• Supplement Date Received by Manufacturer: 01/24/2025
• Initial Report FDA Received Date: 12/13/2024
• Supplement Report FDA Received Date: 01/31/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• Patient Sequence Number: 1
• Outcome Attributed to Adverse Event: Other
• Patient Sex: Unknown